Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Stronger Sell Today FOLD ranks #5926 as SELL CANDIDATE #5926 Weaker Sell

FOLD stock forecast Amicus Therapeutics

FOLD stock forecast

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Read more

Earnings and other concerns held some stocks back Thursday.

Read more

The company announced a significant stock offering.

Read more

Microcaps tops midday movers
04:52pm, Thursday, 30'th May 2019

Read more

2 Ultra-High-Growth Biotech Stocks to Buy Now
02:34pm, Thursday, 30'th May 2019
Amicus Therapeutics and Array BioPharma are two top growth stocks to consider buying now.

Read more

CRANBURY, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ: FOLD ) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, NV on Tuesday, May 14, 2019 at 1:00 p.m. PT. A live audio webcast of the … Full story available on Benzinga.com

Read more

FOLD earnings call for the period ending March 31, 2019.

Read more

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants Sara Pellegrino - Vice President of Investo

Read more

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -25.81% and -9.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank